[1]
Lax S, [Precursor lesions of endometrial carcinoma: diagnostic approach and molecular pathology]. Der Pathologe. 2011 Nov; [PubMed PMID: 22033684]
[2]
Sherman ME,Bur ME,Kurman RJ, p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis. Human pathology. 1995 Nov; [PubMed PMID: 7590703]
[3]
Kandoth C,Schultz N,Cherniack AD,Akbani R,Liu Y,Shen H,Robertson AG,Pashtan I,Shen R,Benz CC,Yau C,Laird PW,Ding L,Zhang W,Mills GB,Kucherlapati R,Mardis ER,Levine DA, Integrated genomic characterization of endometrial carcinoma. Nature. 2013 May 2; [PubMed PMID: 23636398]
[4]
Baloglu H,Cannizzaro LA,Jones J,Koss LG, Atypical endometrial hyperplasia shares genomic abnormalities with endometrioid carcinoma by comparative genomic hybridization. Human pathology. 2001 Jun; [PubMed PMID: 11431716]
[5]
Bell DW,Ellenson LH, Molecular Genetics of Endometrial Carcinoma. Annual review of pathology. 2019 Jan 24; [PubMed PMID: 30332563]
[6]
Sanderson PA,Critchley HO,Williams AR,Arends MJ,Saunders PT, New concepts for an old problem: the diagnosis of endometrial hyperplasia. Human reproduction update. 2017 Mar 1; [PubMed PMID: 27920066]
[7]
Ayhan A,Mao TL,Suryo Rahmanto Y,Zeppernick F,Ogawa H,Wu RC,Wang TL,Shih IeM, Increased proliferation in atypical hyperplasia/endometrioid intraepithelial neoplasia of the endometrium with concurrent inactivation of ARID1A and PTEN tumour suppressors. The journal of pathology. Clinical research. 2015 Jul; [PubMed PMID: 27499903]
[9]
Cote ML,Ruterbusch JJ,Olson SH,Lu K,Ali-Fehmi R, The Growing Burden of Endometrial Cancer: A Major Racial Disparity Affecting Black Women. Cancer epidemiology, biomarkers [PubMed PMID: 26290568]
[10]
Gaber C,Meza R,Ruterbusch JJ,Cote ML, Endometrial Cancer Trends by Race and Histology in the USA: Projecting the Number of New Cases from 2015 to 2040. Journal of racial and ethnic health disparities. 2016 Oct 17; [PubMed PMID: 27753051]
[12]
Ozdegirmenci O,Kayikcioglu F,Bozkurt U,Akgul MA,Haberal A, Comparison of the efficacy of three progestins in the treatment of simple endometrial hyperplasia without atypia. Gynecologic and obstetric investigation. 2011; [PubMed PMID: 21266792]
[13]
Lacey JV Jr,Chia VM,Rush BB,Carreon DJ,Richesson DA,Ioffe OB,Ronnett BM,Chatterjee N,Langholz B,Sherman ME,Glass AG, Incidence rates of endometrial hyperplasia, endometrial cancer and hysterectomy from 1980 to 2003 within a large prepaid health plan. International journal of cancer. 2012 Oct 15; [PubMed PMID: 22290745]
[14]
Mutter GL,Zaino RJ,Baak JP,Bentley RC,Robboy SJ, Benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists. 2007 Apr [PubMed PMID: 17413975]
[15]
Trimble CL,Method M,Leitao M,Lu K,Ioffe O,Hampton M,Higgins R,Zaino R,Mutter GL, Management of endometrial precancers. Obstetrics and gynecology. 2012 Nov; [PubMed PMID: 23090535]
[16]
Emons G,Beckmann MW,Schmidt D,Mallmann P, New WHO Classification of Endometrial Hyperplasias. Geburtshilfe und Frauenheilkunde. 2015 Feb; [PubMed PMID: 25797956]
[17]
Widra EA,Dunton CJ,McHugh M,Palazzo JP, Endometrial hyperplasia and the risk of carcinoma. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 1995 May; [PubMed PMID: 11578482]
[19]
Ancheta E,Perry J,Bernard-Pearl L,Paul S,Darragh T,Smith-McCune K, Participants at the ASCCP 2000 Biennial Meeting adhere to published guidelines in their management of atypical squamous cells and atypical glandular cells on pap test. Journal of lower genital tract disease. 2003 Oct; [PubMed PMID: 17051084]
[20]
Kumari A,Pankaj S,Choudhary V,Kumari J,Nazneen S,Kumari A,Suman SK,Kumar S, Ultrasonic and Histopathological Evaluation to Exclude Premalignant and Malignant Lesions in Perimenopausal and Postmenopausal Women Presenting as Abnormal Uterine Bleeding. Journal of obstetrics and gynaecology of India. 2019 Oct; [PubMed PMID: 31686752]
[21]
Guillon S,Popescu N,Phelippeau J,Koskas M, A systematic review and meta-analysis of prognostic factors for remission in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2019 Sep; [PubMed PMID: 31197826]
[22]
Braun MM,Overbeek-Wager EA,Grumbo RJ, Diagnosis and Management of Endometrial Cancer. American family physician. 2016 Mar 15 [PubMed PMID: 26977831]
[23]
Georgescu TA,Cirstoiu M,Costache M,Lazaroiu A,Dumitru A,Sajin M, Histopathological, Immunohistochemical and Therapeutical Assessment of Premalignant Endometrial Lesions in a Hospital Based Series of Cases. Maedica. 2016 Jun [PubMed PMID: 28461830]
[24]
The American College of Obstetricians and Gynecologists Committee Opinion no. 631. Endometrial intraepithelial neoplasia. Obstetrics and gynecology. 2015 May; [PubMed PMID: 25932867]
[27]
Wang S,Pudney J,Song J,Mor G,Schwartz PE,Zheng W, Mechanisms involved in the evolution of progestin resistance in human endometrial hyperplasia--precursor of endometrial cancer. Gynecologic oncology. 2003 Feb [PubMed PMID: 12586588]
[28]
Huang EC,Mutter GL,Crum CP,Nucci MR, Clinical outcome in diagnostically ambiguous foci of 'gland crowding' in the endometrium. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2010 Nov; [PubMed PMID: 20676062]
[29]
Ip PP, Benign endometrial proliferations mimicking malignancies: a review of problematic entities in small biopsy specimens. Virchows Archiv : an international journal of pathology. 2018 Jun; [PubMed PMID: 29445890]
[30]
Gücer F,Reich O,Tamussino K,Bader AA,Pieber D,Schöll W,Haas J,Petru E, Concomitant endometrial hyperplasia in patients with endometrial carcinoma. Gynecologic oncology. 1998 Apr; [PubMed PMID: 9571000]